170 related articles for article (PubMed ID: 38686279)
1. COVID-Induced Thrombotic Thrombocytopenic Purpura: A Case Report and Treatment-Focused Review.
Waleed MS; Dhulipalla L; Niazi M; Terjanian T; Dhar M
Cureus; 2024 Mar; 16(3):e57252. PubMed ID: 38686279
[TBL] [Abstract][Full Text] [Related]
2. [Frontline clinical practice for thrombotic thrombocytopenic purpura].
Miyakawa Y
Rinsho Ketsueki; 2020; 61(9):1331-1337. PubMed ID: 33162533
[TBL] [Abstract][Full Text] [Related]
3. Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report.
Mousseaux C; Joly BS; Mohamadou I; Arrestier R; Hertig A; Rafat C
BMC Nephrol; 2020 May; 21(1):204. PubMed ID: 32471388
[TBL] [Abstract][Full Text] [Related]
4. A case of thrombotic thrombocytopenic purpura associated with COVID-19.
Nicolotti D; Bignami EG; Rossi S; Vezzani A
J Thromb Thrombolysis; 2021 Aug; 52(2):468-470. PubMed ID: 33389519
[TBL] [Abstract][Full Text] [Related]
5. Refractory Auto-Immune Thrombotic Thrombocytopenic Pupura Successfully Treated With Caplacizumab.
Mellaza C; Henry N; Fayolle PM; Mortaza S; Subra JF; Veyradier A; Coppo P; Augusto JF
Front Med (Lausanne); 2020; 7():549931. PubMed ID: 33195299
[TBL] [Abstract][Full Text] [Related]
6. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
[TBL] [Abstract][Full Text] [Related]
7. Indicators Differentiating Thrombotic Thrombocytopenic Purpura From Other Thrombotic Microangiopathies in a Canadian Apheresis Referral Center.
Martin SD; McGinnis E; Smith TW
Am J Clin Pathol; 2021 Nov; 156(6):1103-1112. PubMed ID: 34160013
[TBL] [Abstract][Full Text] [Related]
8. Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review.
Malgaj Vrečko M; Aleš Rigler A; Večerić-Haler Ž
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232608
[TBL] [Abstract][Full Text] [Related]
9. A Rare Case of Severe Manifestation of COVID-19 Infection Presenting as Immune-Related Thrombotic Thrombocytopenic Purpura With Multiorgan Involvement Treated With Plasmapheresis, Steroids, Rituximab, and Caplacizumab.
Mandyam S; Fatmi SS; Banzon G; Kaur P; Katamreddy Y; Parghi D; Farooq A; Liaqat H; Basarakodu K
Cureus; 2022 Jul; 14(7):e26961. PubMed ID: 35989829
[TBL] [Abstract][Full Text] [Related]
10. First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine - case report.
Osmanodja B; Schreiber A; Schrezenmeier E; Seelow E
BMC Nephrol; 2021 Dec; 22(1):411. PubMed ID: 34895163
[TBL] [Abstract][Full Text] [Related]
11. [Thrombotic thrombocytopenic purpura].
Yoshitaka M
Rinsho Ketsueki; 2021; 62(5):430-434. PubMed ID: 34108326
[TBL] [Abstract][Full Text] [Related]
12. Acquired Thrombotic Thrombocytopenic Purpura After BNT162b2 COVID-19 Vaccine: Case Report and Literature Review.
Hammami E; Lamarque M; Aujoulat O; Debliquis A; Drénou B; Harzallah I
Lab Med; 2022 Nov; 53(6):e145-e148. PubMed ID: 35482291
[TBL] [Abstract][Full Text] [Related]
13. Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies.
Scully M; Cataland S; Coppo P; de la Rubia J; Friedman KD; Kremer Hovinga J; Lämmle B; Matsumoto M; Pavenski K; Sadler E; Sarode R; Wu H;
J Thromb Haemost; 2017 Feb; 15(2):312-322. PubMed ID: 27868334
[TBL] [Abstract][Full Text] [Related]
14. Ceftriaxone-Induced Thrombotic Thrombocytopenic Purpura Treated Successfully With Plasmapheresis and Eculizumab: A Rare Case Report.
Qureshi ZA; Altaf F; Khanzada M; Thet A; Espinosa L
Cureus; 2023 Nov; 15(11):e48898. PubMed ID: 38024015
[TBL] [Abstract][Full Text] [Related]
15. Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).
Shah N; Rutherford C; Matevosyan K; Shen YM; Sarode R
Br J Haematol; 2013 Nov; 163(4):514-9. PubMed ID: 24111495
[TBL] [Abstract][Full Text] [Related]
16. Rituximab for acute plasma-refractory thrombotic thrombocytopenic purpura: A case report.
Chaurasiya PS; Khatri A; Gurung S; Karki S; Shahi S; Aryal L
Ann Med Surg (Lond); 2022 Oct; 82():104789. PubMed ID: 36268380
[TBL] [Abstract][Full Text] [Related]
17. Thrombotic Thrombocytopenic Purpura: A Rare Cause of Severe Acute Kidney Injury.
Najar H; Tuider L; Kukkar V; Quasem M
Cureus; 2022 Apr; 14(4):e24221. PubMed ID: 35602841
[TBL] [Abstract][Full Text] [Related]
18. Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.
Bruzzese A; Vigna E; Terzi D; Greco S; Martino EA; Vangeli V; Mendicino F; Lucia E; Olivito V; Labanca C; Morelli R; Neri A; Morabito F; Zinno F; Mastroianni A; Gentile M
Hematol Rep; 2023 Jul; 15(3):448-453. PubMed ID: 37489376
[TBL] [Abstract][Full Text] [Related]
19. Case report: COVID-19-associated refractory thrombotic thrombocytopenic purpura complicated with Guillain-Barré syndrome.
Zhou R; Chen S; Luo Q; Zhang X; Li F; Huang W; Sheng Z
Front Neurol; 2023; 14():1199889. PubMed ID: 37292131
[TBL] [Abstract][Full Text] [Related]
20. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments - an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES).
Pascual-Izquierdo C; Piñera Salmerón P; Temboury Ruiz F; Valcárcel Ferreiras D; Jiménez Hernández S; Salinas Argente R; Del Arco Galán C; de la Rubia Comos J
Emergencias; 2023 Feb; 35(1):44-52. PubMed ID: 36756916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
